Kopran Ltd dividend

Kopran Ltd dividend

stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

10.3 K

stocks traded


Kopran Ltd




Last updated : FY 2023

Key Highlights

    The Dividend per Share of Kopran Ltd is ₹ 3 as of 2023 .a1#The Dividend Payout of Kopran Ltd changed from 55.28 % on March 2019 to 46.28 % on March 2023 . This represents a CAGR of -5.75% over 3 years. a1#The Latest Trading Price of Kopran Ltd is ₹ 237.7 as of 23 May 11:29 .a1#The Market Cap of Kopran Ltd changed from ₹ 179.93 crore on March 2019 to ₹ 532.49 crore on March 2023 . This represents a CAGR of 24.23% over 5 years. a1#The Revenue of Kopran Ltd changed from ₹ 126.27 crore to ₹ 195.75 crore over 8 quarters. This represents a CAGR of 24.51% a1#The EBITDA of Kopran Ltd changed from ₹ 13.8 crore to ₹ 31.36 crore over 8 quarters. This represents a CAGR of 50.75% a1#The Net Profit of Kopran Ltd changed from ₹ 7.6 crore to ₹ 18.62 crore over 8 quarters. This represents a CAGR of 56.52% a1#

Open Demat Account

Lead form image


50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

Share Price Vs Dividend Yield


Fundamental Metrics

Market Cap

1,184 Cr



P/E Ratio (TTM) *


P/B Ratio (TTM) *








Dividend Yield *




Dividend Payout *


Ann.Dividend % *


* All values are consolidated

* All values are consolidated


Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Mar '190
Mar '200
Mar '2155
Mar '22123
Mar '2346

* All values are a in %

Dividend per Share (DPS) Over Time



Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers





* All values are in %

Net Profit Vs Dividend Per Share


Kopran Ltd





stock direction

Last updated : 23 May 11:29

SWOT Analysis Of Kopran Ltd













Dividend Overview for Kopran Ltd

  • Kopran Ltd, boasts of a market capitalization of Rs 1185 Cr., with a share price of Rs 237.70 as of 23 May 11:29. While all stocks don't consistently pay dividends, Kopran Ltd rewarded its shareholders, distributing 46.3 % for the full year.
  • In the year ending 2022, Kopran Ltd declared a dividend of Rs 3, resulting in a dividend yield of 1.1% Assessing its dividend-paying capacity and valuation is crucial to determine its suitability as a dividend stock.
  • During the year ending 2023, Kopran Ltd recorded revenues of Rs 615 Cr, with a trailing EBITDA Margin of 14.5% and net-profit of Rs 51 Cr

Overview of Dividend

Types of Dividend

Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.

Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.

Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.

Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Mar '19180
Mar '20110
Mar '21454
Mar '221357
Mar '23532

* All values are a in crore


Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Jun '22126
Sep '22117
Dec '22160
Mar '22153
Jun '23119
Sep '23153
Dec '23161
Mar '23196

* All values are a in crore


EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Jun '2214
Sep '2211
Dec '2215
Mar '2216
Jun '239
Sep '2323
Dec '2326
Mar '2331

* All values are a in crore


Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Jun '228
Sep '225
Dec '227
Mar '228
Jun '233
Sep '2314
Dec '2316
Mar '2319

* All values are a in crore

About Kopran Ltd

About Kopran Ltd

    Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises. The company came out with a public issue at a premium, in Nov.'92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility. Kopran manufactures pharmaceutical finished dosage forms and bulk drugs and distributes electronic equipment. It manufactures semi-synthetic penicillin and is among the world's highest producers in amoxycillin. Kopran also makes penicillin-G acylase, an enzyme made through fermentation. It has technical collaborations with Gesellschaft Fur Biotechnologische, Germany; Yuhan Corporation, South Korea; Ciba Corning Diagnostic, US; and Adac Laboratories, US. Kopran's bulk drug plant has been approved by the US FDA and the UK regulatory authorities. In 1995, the company was awarded the Quality Excellence award by the Indian Drug Manufacturers Association. Kopran's high growth rate in exports has been recognised by a number of awards from CHEMEXCIL and the Ministry of Commerce. The company launched new products like AZ-1 Caps, Klodip Tabs, Moclox Kid Tabs, Amyn Kid Tabs, Tini-NF, Amyn Caps and Amyn Dry Syrup. Kopran entered into a joint venture with M/s Industrial Promotion Services Ltd to take over a running unit viz Kampala Pharmaceuticals Industries Ltd in Uganda. The company has been ranked as amongst the top few fastest growing companies in India(ORG Marg-June 2000). It closed down its manufacturing facility at Saki Naka, Andheri, Bombay. Globalpharma, a joint venture with Dubai Investments Corporation started commercial production in the first quarter of 2002. The company has increased its installed capacity of Liquids by 3.00 lakhs of Litres during 2001 and consequent of this capacity expansion the total installed capacity has gone up to 12.00 lakhs of Litres. The company has also increased its installed capacity of Tablets & Capsules by 270 crores(Nos) and the total capacity has gone up to 1080 crores(Nos). In Feb. 2001, Kopran tied up with E-Merck for co-marketing a new anti-inflammatory drug, Rofecoxib, in India. Rofecoxib is one of the fast-moving non-steroid anti-inflammatory drugs (NSAID),has been launched in the international market. The Company also launched Cholestat (Atorvastatin - a cholesterol reducer) and further gave co-marketing rights for Atorvastatin to E-Merck (India). The company had launched new products in therapeutic groups like Asthma,Cardiology,Diabetes and Lifestyle products during 2003.The company has obtained approval from European Directorate for Quality of Medicines(EDQM) in September 2003. Upgradation of Formulation Manufacturing facility took place to meet with the latest International Regulatory Norms.The United Kingdom Medicines and Healthcare Products Regulatory Agency(UK MHRA) is expected to inspect the facilities in the first quarter of 2004. Kopran Pharmaceuticals Ltd., the Company marketing the SMYLE brand of products was merged into the Company effective from 1st March, 2005. The Company introduced two new bulk drugs viz. Pregabalin and Cefditorin during the year 2007. The Company during the FY 2014-15 sold the Active Pharmaceuticals Ingredients (API) business on slump sale basis to its subsidiary Kopran Research Laboratories Ltd. at a consideration of Rs 110 Crores on 30th March, 2015. Similarly, the Consumer Care Division was sold w.e.f 1 April 2015.

Kopran Ltd News Hub


Kopran schedules AGM

Kopran announced that the 65th Annual General Meeting(AGM) of the company will be held on ...

Read more

16 May 2024 16:32


Board of Kopran recommends Final Dividend

Kopran announced that the Board of Directors of the Company at its meeting held on 16 May ...

Read more

16 May 2024 14:23


Kopran to announce Quarterly Result

Kopran will hold a meeting of the Board of Directors of the Company on 16 May 2024 Powered...

Read more

08 May 2024 16:09


Kopran to announce Quarterly Result

Kopran will hold a meeting of the Board of Directors of the Company on 7 February 2024. Po...

Read more

23 Jan 2024 16:22


Kopran to conduct board meeting

Kopran will hold a meeting of the Board of Directors of the Company on 7 November 2023. Po...

Read more

27 Oct 2023 16:52


Kopran to conduct AGM

Kopran announced that the Annual General Meeting (AGM) of the company will be held on 14 S...

Read more

19 Aug 2023 11:51

FAQs for dividends of Kopran Ltd

What is the current market price of Kopran Ltd Ltd as of May 23, 2024?

The current market price of Kopran Ltd Ltd stands at 237.7 per share.

What dividend did Kopran Ltd declare in the last fiscal year?

In the last fiscal year, Kopran Ltd declared a dividend totaling ₹3.0.

What is the most recent dividend declared by Kopran Ltd?

Kopran Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Kopran Ltd declared dividends in the current fiscal year

Kopran Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Kopran Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Kopran Ltd declared dividends 4 times totaling ₹0.
up arrow

Unlimited trading at just

Rs. 399

Rs. 199